Capital Analysts, LLC Maxcyte, Inc. Transaction History
Capital Analysts, LLC
- $2.26 Billion
- Q2 2024
A detailed history of Capital Analysts, LLC transactions in Maxcyte, Inc. stock. As of the latest transaction made, Capital Analysts, LLC holds 1,266 shares of MXCT stock, worth $4,684. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,266
Previous 1,266
-0.0%
Holding current value
$4,684
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MXCT
# of Institutions
118Shares Held
65MCall Options Held
600Put Options Held
2.7K-
Black Rock Inc. New York, NY8.14MShares$30.1 Million0.0% of portfolio
-
Cadian Capital Management, LP New York, NY7.62MShares$28.2 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.65MShares$20.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$19.2 Million0.01% of portfolio
-
Vitruvian Partners LLP5.04MShares$18.7 Million5.8% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $376M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...